"Understanding Clinical Trial Equity: Focusing on Disease Impact Beyond Representation"

Clinical trials are essential for medical advancements, yet participant representation often relies on flawed methods. A new commentary in Nature suggests using disease incidence rates instead of Census data to ensure equitable representation. This approach allows for better inclusion of underrepresented groups, ultimately improving healthcare outcomes for all communities.